Strides Pharma Science Limited has informed the Exchange regarding a press release dated May 19, 2023, titled "Strides Puducherry facility receives Establishment Inspection Report (EIR) from USFDA confirming the reclassification of the site from Official Action Indicated (OAI) to Voluntary Action Indicated (VAI)".
Strides Pharma Science Ltd Press Release May 19 2023
Filed with NSE · · 1 page · English
Release
Strides Pharma Science Ltd on 6ix
Earlier from Strides Pharma Science
- Press Release May 03 2023
- Press Release Feb 24 2023
- Earnings Update_Q2FY23
- Earnings Update_Q3FY23
- Press Release Jan 20 2023
Later from Strides Pharma Science
- Press Release May 25 2023
- Press Release Jul 04 2023
- Intimation of Board Meeting scheduled on August 2, 2023
- Press Release Aug 02 2023
- Press Release Aug 30 2023
Follow Strides Pharma Science into a list and get an email when it puts out news.
Follow Strides Pharma Science